Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
This will be a multicenter prospective study. We will recruit ten (10) healthy participants aged 20 to 30 years to investigate the feasibility and test/retest reliability of the REPSI sequence. Twenty five (25) HIV+ patients will be recruited from the Division of HIV Medicine (Dr. Eric Daar) at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (Torrance, CA). HIV+ patients will be transported to the UCLA Medical center for neuroimaging examination.
Age
20–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
HIV-infected between age of 20 and 65 years
Consistently have plasma HIV RNA levels \<200 copies/mL for at least the last 12 months on a stable antiretroviral regimen with any changes made only for convenience, safety or simplicity.
Able to provide informed consent.
You may not be if
HIV negative
Clareo Health | MR Imaging and MR Spectroscopy of HIV
